Aligo Innovation

Calogy Solutions specializes in developing advanced thermal management technologies tailored for electric transportation applications. The company offers a range of solutions including thermal and CFD calculations for electronics thermal management, custom-designed compact liquid cooling systems, heat pipes, vapor chambers, and comprehensive thermal characterization, testing, and validation services. These services involve exposing microelectronic components to various temperature conditions to help clients identify and address thermal challenges in their products, ultimately enhancing safety, increasing component lifetime, and reducing initial costs of vehicles.

Laurent Pharmaceuticals Inc., established in 2012 and based in Montreal, Canada, is a biopharmaceutical company focused on developing orally-active drug candidates to modulate the immuno-inflammatory response in cystic fibrosis patients. Its lead product, LAU-7b, is a novel once-a-day oral form of fenretinide currently in clinical development stages.

SPARK Microsystems is a fabless semiconductor company specializing in ultra-low power wireless communication technologies for the Internet of Things (IoT). The company develops a high-performance wireless transceiver that significantly enhances energy efficiency and reduces latency, achieving faster data rates compared to existing solutions. SPARK Microsystems' patented technology extends the battery life of electronic devices, enabling the possibility of battery-less operation for wireless devices. This innovation is poised to play a crucial role in the advancement of IoT applications, facilitating more efficient and sustainable wireless communication.

Ovensa is a biotechnology company developing nanomedicine platforms to deliver targeted therapies across various barriers, including the blood-brain barrier. It focuses on treating cancer and neurodegenerative diseases while also preventing antibiotic resistance.

Ovensa is a biotechnology company developing nanomedicine platforms to deliver targeted therapies across various barriers, including the blood-brain barrier. It focuses on treating cancer and neurodegenerative diseases while also preventing antibiotic resistance.

Laurent Pharmaceuticals Inc., established in 2012 and based in Montreal, Canada, is a biopharmaceutical company focused on developing orally-active drug candidates to modulate the immuno-inflammatory response in cystic fibrosis patients. Its lead product, LAU-7b, is a novel once-a-day oral form of fenretinide currently in clinical development stages.

wrnch is a computer vision and deep learning software engineering company based in Montréal, Canada, known for its innovative contributions to artificial intelligence, special effects, and game technology. Founded by Dr. Paul Kruszewski, a seasoned AI entrepreneur, wrnch has developed a real-time software platform that enables cameras to understand and interpret human motion and activity in video. Utilizing a deep learning runtime engine, the company's technology performs human pose estimation by analyzing standard 2D video and generating 3D motion data in real time. This capability allows wrnch to process multiple 2D camera feeds while tracking various body parts, making its solutions applicable across diverse industries such as robotics, retail, and entertainment. The company has achieved profitability and has garnered support from experienced investors.